Science & Enterprise subscription

Follow us on Twitter

  • The advocacy group Union of Concerned Scientists says space is an arena where most activity is for peaceful purpose… https://t.co/fs1QetgIws
    about 3 hours ago
  • New post on Science and Enterprise: Infographic – Countries with Most Space Satellites https://t.co/esIANqtGob #Science #Business
    about 3 hours ago
  • New contributed post on Science and Enterprise: https://t.co/Abq3ICK7BT Getting Into Auto Trading
    about 4 hours ago
  • A bioinformatics lab developed a prototype system for securely transmitting and storing clinical trial data with b… https://t.co/uXDzGN4Ezh
    about 20 hours ago
  • New post on Science and Enterprise: Blockchain Prototype Designed for Clinical Trial Data https://t.co/XNsa4huy1d #Science #Business
    about 20 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Handshake

Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Model Biotech Materials Sharing Agreement Unveiled

Lab jars and beakers

A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs. . . . → Read More: Model Biotech Materials Sharing Agreement Unveiled

Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

T-cells illustration

A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

Biotech in $3.7B Licensing Deal for Hepatitis-B

Hepatitis-B virus

A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B

Patents Awarded for Stem Cell Heart Disease Technologies

U.S. Patent and Trademark Office

A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies

Gilead Gains Genome-Editing Hepatitis B Therapy

Hepatitis-B virus

Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver. . . . → Read More: Gilead Gains Genome-Editing Hepatitis B Therapy

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

Infographic – Google A.I. Patents Lead Other Tech Companies

Google A.I. patents

According to a new report, Alphabet, the company formerly known as Google, is leading other big tech companies in patent activity for artificial intelligence applications. . . . → Read More: Infographic – Google A.I. Patents Lead Other Tech Companies

Baby Box Technology for Sick Newborns Licensed to Start-Up

Newborn in incubator

A start-up company is gaining the rights to a technology that helps the breathing of infants suffering from withdrawal from drugs taken by their mothers, and other disruptive conditions. . . . → Read More: Baby Box Technology for Sick Newborns Licensed to Start-Up

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine